By Josh Nolan, The Chronicus Post
23 February 2010
Yesterday, Wisconsin’s Department of Commerce announced their top 30 companies to watch in 2010. The purpose of the award is to honor second-stage companies that demonstrate high performance in the marketplace, exhibit innovative products, services or processes, or otherwise make their company “worth watching.” Among these companies were numerous pharmaceutical and biotechnology companies whose focus are chronic diseases.